Risk variation in celiac disease in a population from Southern Spain: evaluating the influence of the DQB1*02:02 allele frequency

References

• Sollid LM, Jabri B. Is celiac disease an autoimmune disorder? Curr Opin Immunol. 2005;17:595–600.
   PubMed Web of Science ®Google Scholar
• Briani C, Samaroo D, Alaedini A. Celiac disease: from gluten to autoimmunity. Autoimmun Rev. 2008;7:644–650.
   PubMed Web of Science ®Google Scholar
• Koning F. Pathophysiology of celiac disease. J Pediatr Gastroenterol Nutr. 2014;59(1):S1–S4.
   Web of Science ®Google Scholar
• Tjon JM, van Bergen J, Koning F. Celiac disease: how complicated can it get? Immunogenetics. 2010;62:641–651.
   PubMed Web of Science ®Google Scholar
• Mustalahti K, Catassi C, Reunanen A, et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med. 2010;42:587–595.
   PubMed Web of Science ®Google Scholar
• Catassi C, Kryszak D, Bhatti B, et al. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med. 2010;42:530–538.
   PubMed Web of Science ®Google Scholar
• White LE, Merrick VM, Bannerman E, et al. The rising incidence of celiac disease in Scotland. Pediatrics. 2013;132:e924–e931.
   PubMed Web of Science ®Google Scholar
• Catassi C, Gatti S, Fasano A. The new epidemiology of celiac disease. J Pediatr Gastroenterol Nutr. 2014;59(1):S7–S9.
   PubMed Web of Science ®Google Scholar
• Vader W, Stepniak D, Kooy Y, et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci USA. 2003;100:12390–12395.
   PubMed Web of Science ®Google Scholar
• Ploski R, Ek J, Thorsby E, et al. On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens. 1993;41:173–177.
   PubMed Web of Science ®Google Scholar
• van Belzen MJ, Koeleman BP, Crusius JB, et al. Defining the contribution of the HLA region to cis DQ2-positive coeliac disease patients. Genes Immun. 2004;5:215–220.
   PubMed Web of Science ®Google Scholar
• Margaritte-Jeannin P, Babron MC, Bourgey M, et al. HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease. Tissue Antigens. 2004;63:562–567.
   PubMed Web of Science ®Google Scholar
• Murray JA, Moore SB, Van Dyke CT, et al. HLA DQ gene dosage and risk and severity of celiac disease. Clin Gastroenterol Hepatol. 2007;5:1406–1412.
   PubMed Web of Science ®Google Scholar
• Pietzak MM, Schofield TC, McGinniss MJ, et al. Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles. Clin Gatroenterol Hepatol. 2009;7:966–971.
   PubMed Web of Science ®Google Scholar
• Meddeb-Garnaoui A, Zeliszewski D, Mougenot JF, et al. Reevaluation of the relative risk for susceptibility to celiac disease of HLA-DRB1, -DQA1, -DQB1, -DPB1, and -TAP2 alleles in a French population. Hum Immunol. 1995;43:190–199.
   PubMed Web of Science ®Google Scholar
• Louka AS, Nilsson S, Olsson M, et al. HLA in coeliac disease families: a novel test of risk modification by the other haplotype when at least one DQA1*05-DQB1*02 haplotype is carried. Tissue Antigens. 2002;60:147–154.
   PubMed Web of Science ®Google Scholar
• Hernández-Charro B, Donat E, Miner I, et al. Modifying effect of HLA haplotypes located trans to DQB1*02-DRB1*03 in celiac patients of Southern Europe. Tissue Antigens. 2008;71:213–218.
   PubMed Web of Science ®Google Scholar
• Husby S, Koletzko S, Korponay-Szabó IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54:136–160.
   PubMed Web of Science ®Google Scholar
• Green PH, Lebwohl B, Greywoode R. Celiac disease. J Allergy Clin Immunol. 2015;135:1099–1106.
   PubMed Web of Science ®Google Scholar
• Dubois PC, Trynka G, Franke L, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet. 2010;42:295–302.
   PubMed Web of Science ®Google Scholar
• Trynka G, Hunt KA, Bockett NA, et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet. 2011;43:1193–1201.
   PubMed Web of Science ®Google Scholar
• Parkes M, Cortes A, van Heel DA, et al. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat Rev Genet. 2013;14:661–673.
   PubMed Web of Science ®Google Scholar
• Wijmenga C, Gutierrez-Achury J. Celiac disease genetics: past, present and future challenges. J Pediatr Gastroenterol Nutr. 2014;59(1):S4–S7.
   Web of Science ®Google Scholar
• Polvi A, Arranz E, Fernández-Arquero M, et al. HLA-DQ2-negative celiac disease in Finland and Spain. Hum Immunol. 1998;59:169–175.
   PubMed Web of Science ®Google Scholar
• Karell K, Louka AS, Moodie SJ, et al. types in celiac disease patients not carrying the DQA*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol. 2003;64:469–477.
   PubMed Web of Science ®Google Scholar
• Mubarak A, Spierings E, Wolters V, et al. Human leukocyte antigen DQ2.2 and celiac disease. J Pediatr Gastroenterol Nutr. 2013;56:428–430.
   PubMed Web of Science ®Google Scholar
• Henderson KN, Tye-Din JA, Reid HH, et al. A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease. Immunity. 2007;27:23–34.
   PubMed Web of Science ®Google Scholar
• Broughton SE, Petersen J, Theodossis A, et al. Biases T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac disease. Immunity. 2012;37:611–621.
   PubMed Web of Science ®Google Scholar
• Delgado JF, Amengual MJ, Veraguas A, et al. Paediatric celiac patients carrying the HLA-DR7-DQ2 and HLA-DR3-DQ2 haplotypes display small clinical differences. Acta Paediatr. 2014;103:e238–e242.
   PubMed Web of Science ®Google Scholar
• Qiao SW, Bergseng E, Molberg O, et al. Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation. J Immunol. 2005;175:254–261.
   PubMed Web of Science ®Google Scholar
• Fallang LE, Bergseng E, Hotta K, et al. Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. Nat Immunol. 2009;10:1096–1101.
   PubMed Web of Science ®Google Scholar
• Bodd M, Kim CY, Lundin KE, et al. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease. Gastroenterology. 2012;142:552–561.
   PubMed Web of Science ®Google Scholar
• Lauret E, Rodrigo L. Celiac disease and autoimmune-associated conditions. Biomed Res Int. 2013;2013:127589.
   PubMed Web of Science ®Google Scholar
• Smigoc Schweiger D, Mendez A, Kunilo Jamnik S, et al. High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease. Autoimmun. 2016;49:240–247.
   PubMed Web of Science ®Google Scholar
• Ruiz-Ortiz E, Montraveta M, Cabré E, et al. HLA-DQ2/DQ8 and HLA-DQB1*02 homozygosity typing by real-time polymerase chain reaction for the assessment of celiac disease genetic risk: evaluation of a Spanish celiac population. Tissue Antigens. 2014;84:545–553.
   PubMedGoogle Scholar
• Selleski N, Almeida LM, Almeida FC, et al. Simplifying celiac disease predisposing HLA-DQ alleles determination by the real time PCR method. Arq Gastroenterol. 2015;52:143–146.
   PubMedGoogle Scholar